证券记录 · 已归档季度
FULC
Fulcrum Therapeutics, Inc. · Healthcare · Biotechnology
15被追踪持有人
+2Δ持有人
16.83M持有股份
$115.80M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +15.4% ·
股份流向 +14.9% ·
净新建仓位 +13.3%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | -4 | 45.92M | $168.41M | +4 | −8 |
| Q1 2026 | 78 | +4 | 31.56M | $242.15M | +9 | −5 |
| Q4 2025 | 74 | +3 | 26.56M | $300.41M | +3 | — |
| Q3 2025 | 15 | -3 | 15.03M | $138.26M | — | −3 |
| Q2 2025 | 15 | +2 | 16.83M | $115.80M | +2 | — |
| Q1 2025 | 10 | 0 | 7.12M | $20.50M | +1 | −1 |
| Q4 2024 | 10 | 0 | 6.97M | $32.77M | — | — |
| Q3 2024 | 9 | -1 | 6.03M | $21.54M | +1 | −2 |
| Q2 2024 | 10 | — | 5.45M | $33.81M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 4.59M | +53.0% | $31.57M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 4.38M | — | $30.13M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 3.15M | — | $21.65M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 3.15M | — | $21.65M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 3.15M | — | $21.65M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (被动) | 1.22M | -2.7% | $8.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 1.19M | -3.1% | $8.21M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 1.19M | -3.1% | $8.21M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 1.18M | +102.7% | $8.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 1.18M | +102.7% | $8.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 498.22K | 新增 | $3.43M | 0.0% | New | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 166.23K | -55.6% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 166.23K | -55.6% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 126.40K | 新增 | $869,646 | 0.0% | New | 1 | SEC ↗ |
| 21 | Wellington Management ✦ | 126.40K | 新增 | $869,646 | 0.0% | New | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 126.40K | 新增 | $869,646 | 0.0% | New | 1 | SEC ↗ |
| 23 | Millennium Management ✦ | 105.69K | +159.7% | $727,168 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 78.50K | -80.4% | $540,080 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 69.03K | -1.6% | $475,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 58.97K | -60.8% | $405,679 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 18.05K | +2.5% | $124,205 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 18.05K | +2.5% | $124,205 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 18.05K | +2.5% | $124,205 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 6.97K | — | $47,933 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $3.43M | 0.0% |
| Wellington Management | $869,646 | 0.0% |
| Wellington Management | $869,646 | 0.0% |
| Wellington Management | $869,646 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 167 持有人, 71.69M 股份, $540.27M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据